Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-15, Stock:PFE, The news for the past five days is as follows:
2019-07-08: NEWS1: What Happened in the Stock Market Today.NEWS2: Health Care Sector Update for 07/08/2019: SOLY,PRVL,SGMO,ITCI.NEWS3: Health Care Sector Update for 07/08/2019: SOLY,PRVL,SGMO,ITCI.NEWS4: Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its Rivals.NEWS5: Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study.NEWS6: Here's Why Sangamo Therapeutics Is Surging Today.NEWS7: Here's Why Sangamo Therapeutics Is Surging Today.NEWS8: Health Care Sector Update for 07/08/2019: PRVL,SGMO,ITCI.NEWS9: Health Care Sector Update for 07/08/2019: PRVL,SGMO,ITCI.NEWS10: Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019.NEWS11: Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019.NEWS12: Pfizer Looks Pretty Smart With Array BioPharma Purchase. Here’s Why..NEWS13: Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?.NEWS14: Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?.NEWS15: Why Exact Sciences Corporation Stock Gained Nearly 14% in June.NEWS16: Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN.NEWS18: Pfizer Is Looking Pretty Smart With Array BioPharma Purchase.
2019-07-09: NEWS1: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS2: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS3: BioMarin (BMRN) to File for Hemophilia A Candidate in Q4.NEWS4: BioMarin (BMRN) to File for Hemophilia A Candidate in Q4.NEWS5: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study.NEWS6: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study.NEWS7: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS8: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS9: Dow Movers: MMM, MRK.NEWS10: Dow Movers: MMM, MRK.NEWS11: Judge rules against Trump on drug pricing disclosures.NEWS12: Amarin Thinks Sales of Its Cardio Drug Could Be in the Billions.NEWS13: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study.NEWS14: BioMarin (BMRN) to File for Hemophilia A Candidate in Q4.NEWS15: Women Health a Top Priority Now: 3 Stocks to Watch.NEWS16: Women Health a Top Priority Now: 3 Stocks to Watch.NEWS17: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS18: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS20: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS21: Women Health a Top Priority Now: 3 Stocks to Watch.NEWS22: Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study.NEWS23: Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study.
2019-07-10: NEWS1: US Indexes Close Higher After Dovish Fed Reports.NEWS2: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.NEWS3: The 10 Biggest Healthcare Stocks.NEWS4: Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA.NEWS5: Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA.NEWS6: Companies to Watch: T-Mobile joins S&P 500, Tesla to ramp up production, Marriott faces lawsuit.NEWS7: Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA.NEWS8: Here's Why Array BioPharma Soared 75.4% in June.NEWS9: Here's Why Array BioPharma Soared 75.4% in June.NEWS10: Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Here&apos;s Why Array BioPharma Soared 75.4% in June.NEWS13: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS14: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS15: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS16: Aerie Completes Enrollment Under Rhopressa Study in Japan.
2019-07-11: NEWS1: US STOCKS-S&P 500, Dow climb as health insurers, financials gain.NEWS2: Drug distributors surge, drug makers tumble after Trump administration reverses stance on rebates.NEWS3: The Dow components that drove the blue-chip stock index to a 27,000 milestone.NEWS4: 4 Drug Stocks Getting Smashed.NEWS5: Here's Why CVS Health Stock Is On the Move Today.NEWS6: Here's Why CVS Health Stock Is On the Move Today.NEWS7: Drug Stocks Are Falling Because Trump’s Next Move on Pricing Could Be Trouble.NEWS8: Here are the Dow components driving the  blue-chip stock index to a 27,000 milestone.NEWS9: Here&apos;s Why CVS Health Stock Is On the Move Today.NEWS10: Dow Movers: MRK, UNH.NEWS11: Dow Movers: MRK, UNH.NEWS12: SSO, BRK.B, PFE, CVX: ETF Inflow Alert.NEWS13: SSO, BRK.B, PFE, CVX: ETF Inflow Alert.NEWS14: Here's Why Sangamo Therapeutics Jumped 23% in June.NEWS15: Here's Why Sangamo Therapeutics Jumped 23% in June.NEWS16: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS18: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS19: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS20: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS21: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS22: Here&apos;s Why Sangamo Therapeutics Jumped 23% in June.NEWS23: UPDATE 2-Walgreens expands epinephrine shot partnership as shortage persists.NEWS24: Pfizer Stock Is The Biggest Pharma — But Should You Buy It?.NEWS25: Pfizer Falls 3%.NEWS26: Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised).NEWS27: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.NEWS28: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.
2019-07-12: NEWS1: Health companies start reporting earnings next week: Here are 3 things to keep in mind.NEWS2: AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC.NEWS3: AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC.NEWS4: Dow Movers: PFE, DOW.NEWS5: Dow Movers: PFE, DOW.NEWS6: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS7: AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC.NEWS8: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS9: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.NEWS10: Why one top exec at this $105 billion drugmaker is 'very disappointed' with Trump.NEWS11: Health Care stocks help lead Wall Street rally.NEWS12: Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN.NEWS14: SNY or PFE: Which Is the Better Value Stock Right Now?.NEWS15: Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY.

Answer: Rise